Author response for "Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer"
Marina N. Sharifi(University of Wisconsin–Madison), Martin Sjöström(University of California, San Francisco), Aishwarya Subramanian(Hospital for Sick Children), Nicholas R. Rydzewski(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Anders Bjartell(Lund University), Manish Kohli(Mayo Clinic in Arizona), Kyle T. Helzer(University of Wisconsin–Madison), Alex H. Chang(University of Wisconsin Carbone Cancer Center), Pernilla Wikström(Umeå University), Yue Shi(University of Wisconsin–Madison), Eric Feng(University of California, San Francisco), David A. Quigley(Universidad Católica de Santa Fe), Jamie M. Sperger(University of Wisconsin–Madison), Grace C. Blitzer(University of Wisconsin–Madison), Scott M. Dehm(University of Minnesota), Amy K. Taylor(University of Wisconsin–Madison), Rendong Yang(University of Minnesota System), Andreas Josefsson(University of Gothenburg), Matthew L. Bootsma(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), Rahul Aggarwal(UCSF Helen Diller Family Comprehensive Cancer Center), Luke A. Nunamaker(University of Wisconsin–Madison), V. Carreño(University of Wisconsin–Madison), Emily Feng(University of California, San Francisco), Tianfu Andy Shang(University of Wisconsin–Madison), Eric J. Small(CancerCare Manitoba)
Cited by 0
Related Papers
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k